The cash price of the popular weight-loss drug Wegovy was lowered by 30% on Monday, now priced at $349, down from $499.

Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.

For decades, WeightWatchers dominated the weight-loss industry with community support groups, motivational meetings, and a ...

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and ...

Using a strategic mix of plant-based foods, the Portfolio Diet can lower LDL cholesterol nearly as much as some prescription ...

GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long ...

She's the one - or, is she? Robbie Williams has admitted he can no longer fully see his fans while he's serenading them with ...

Direct-to-consumer sales of medications often mean lower prices and more convenience for patients.

WeightWatchers' CEO said on Wednesday it planned to offer Novo Nordisk's much-anticipated Wegovy in pill form if it is ...

Injectable weight loss drugs have seized the spotlight in recent years. A promise of appetite control in a prescription.

One of the biggest gripes around weight loss medications like Wegovy and Zepbound is the high price tag. At $1,000 or more a ...

Eli Lilly is dropping CVS Health's drug benefit plan for its employees after the healthcare conglomerate stopped covering the company's weight-loss drug in favor of Novo Nordisk's rival medication, ...